Recent News

• 04.08.2025 - Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT
• 04.08.2025 - Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT
• 04.03.2025 - Q4 2024
• 04.03.2025 - Q4 2024
• 03.13.2025 - Rallybio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
• 03.13.2025 - Rallybio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 02.25.2025 - Rallybio to Present at the TD Cowen 45th Annual Health Care Conference
• 02.25.2025 - Rallybio to Present at the TD Cowen 45th Annual Health Care Conference

Recent Filings

• 04.07.2025 - DEF 14A Other definitive proxy statements
• 03.13.2025 - EX-99.1 EX-99.1
• 03.13.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.13.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.13.2025 - 8-K Current report
• 03.13.2025 - 8-K Current report
• 02.25.2025 - 8-K Current report
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities